ID   FGD4_RAT                Reviewed;         766 AA.
AC   O88387;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   24-JUL-2024, entry version 134.
DE   RecName: Full=FYVE, RhoGEF and PH domain-containing protein 4;
DE   AltName: Full=Actin filament-binding protein frabin;
DE   AltName: Full=FGD1-related F-actin-binding protein;
GN   Name=Fgd4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 41-65; 236-252; 276-291;
RP   365-396; 464-475; 478-493; 496-503; 510-551; 702-710 AND 716-428,
RP   HOMOOLIGOMERIZATION, AND FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=9668039; DOI=10.1074/jbc.273.30.18697;
RA   Obaishi H., Nakanishi H., Mandai K., Satoh K., Satoh A., Takahashi K.,
RA   Miyahara M., Nishioka H., Takaishi K., Takai Y.;
RT   "Frabin, a novel FGD1-related actin filament-binding protein capable of
RT   changing cell shape and activating c-Jun N-terminal kinase.";
RL   J. Biol. Chem. 273:18697-18700(1998).
RN   [2]
RP   FUNCTION, ACTIN FIBER-BINDING DOMAIN, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=10464238; DOI=10.1074/jbc.274.36.25197;
RA   Umikawa M., Obaishi H., Nakanishi H., Satoh-Horikawa K., Takahashi K.,
RA   Hotta I., Matsuura Y., Takai Y.;
RT   "Association of frabin with the actin cytoskeleton is essential for
RT   microspike formation through activation of Cdc42 small G protein.";
RL   J. Biol. Chem. 274:25197-25200(1999).
CC   -!- FUNCTION: Activates CDC42, a member of the Ras-like family of Rho- and
CC       Rac proteins, by exchanging bound GDP for free GTP. Plays a role in
CC       regulating the actin cytoskeleton and cell shape. Activates MAPK8.
CC       {ECO:0000269|PubMed:10464238, ECO:0000269|PubMed:9668039}.
CC   -!- SUBUNIT: Homooligomer.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:10464238}. Cell projection, filopodium
CC       {ECO:0000269|PubMed:10464238}. Note=Concentrated in filopodia and
CC       poorly detected at lamellipodia. Binds along the sides of actin fibers.
CC   -!- TISSUE SPECIFICITY: Detected in brain, lung, liver, skeletal muscle,
CC       kidney, testis and cultured hippocampal neurons.
CC       {ECO:0000269|PubMed:10464238}.
CC   -!- DOMAIN: The part of the protein spanning the actin filament-binding
CC       domain together with the DH domain and the first PH domain is necessary
CC       and sufficient for microspike formation. Activation of MAPK8 requires
CC       the presence of all domains with the exception of the actin filament-
CC       binding domain.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF038388; AAC27698.1; -; mRNA.
DR   RefSeq; NP_640356.1; NM_139263.1.
DR   AlphaFoldDB; O88387; -.
DR   SMR; O88387; -.
DR   STRING; 10116.ENSRNOP00000074767; -.
DR   PhosphoSitePlus; O88387; -.
DR   PaxDb; 10116-ENSRNOP00000002491; -.
DR   Ensembl; ENSRNOT00000084177.2; ENSRNOP00000074767.2; ENSRNOG00000059491.2.
DR   Ensembl; ENSRNOT00055004930; ENSRNOP00055003653; ENSRNOG00055003163.
DR   Ensembl; ENSRNOT00060004232; ENSRNOP00060002972; ENSRNOG00060002642.
DR   Ensembl; ENSRNOT00065013507; ENSRNOP00065010011; ENSRNOG00065008509.
DR   AGR; RGD:708357; -.
DR   RGD; 708357; Fgd4.
DR   eggNOG; KOG4424; Eukaryota.
DR   GeneTree; ENSGT00940000155765; -.
DR   InParanoid; O88387; -.
DR   OrthoDB; 5385125at2759; -.
DR   PhylomeDB; O88387; -.
DR   Reactome; R-RNO-193648; NRAGE signals death through JNK.
DR   Reactome; R-RNO-416482; G alpha (12/13) signalling events.
DR   Reactome; R-RNO-9013148; CDC42 GTPase cycle.
DR   PRO; PR:O88387; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0030175; C:filopodium; ISO:RGD.
DR   GO; GO:0030027; C:lamellipodium; ISO:RGD.
DR   GO; GO:0003779; F:actin binding; IDA:MGI.
DR   GO; GO:0051015; F:actin filament binding; IMP:RGD.
DR   GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0007010; P:cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0046847; P:filopodium assembly; IBA:GO_Central.
DR   GO; GO:0030032; P:lamellipodium assembly; ISO:RGD.
DR   GO; GO:0030035; P:microspike assembly; ISO:RGD.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; IMP:RGD.
DR   GO; GO:0043507; P:positive regulation of JUN kinase activity; IDA:MGI.
DR   GO; GO:0008360; P:regulation of cell shape; IMP:RGD.
DR   CDD; cd15741; FYVE_FGD1_2_4; 1.
DR   CDD; cd15791; PH1_FDG4; 1.
DR   CDD; cd13236; PH2_FGD1-4; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; Dbl homology (DH) domain; 1.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 2.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR037742; FDG4_N_PH.
DR   InterPro; IPR035941; FGD1-4_PH2.
DR   InterPro; IPR051092; FYVE_RhoGEF_PH.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR000306; Znf_FYVE.
DR   InterPro; IPR017455; Znf_FYVE-rel.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   PANTHER; PTHR12673; FACIOGENITAL DYSPLASIA PROTEIN; 1.
DR   PANTHER; PTHR12673:SF98; FYVE, RHOGEF AND PH DOMAIN-CONTAINING PROTEIN 4; 1.
DR   Pfam; PF01363; FYVE; 1.
DR   Pfam; PF00169; PH; 2.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00064; FYVE; 1.
DR   SMART; SM00233; PH; 2.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; DBL homology domain (DH-domain); 1.
DR   SUPFAM; SSF50729; PH domain-like; 2.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 2.
DR   PROSITE; PS50178; ZF_FYVE; 1.
PE   1: Evidence at protein level;
KW   Actin-binding; Cell projection; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Guanine-nucleotide releasing factor;
KW   Metal-binding; Phosphoprotein; Reference proteome; Repeat; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..766
FT                   /note="FYVE, RhoGEF and PH domain-containing protein 4"
FT                   /id="PRO_0000080949"
FT   DOMAIN          206..393
FT                   /note="DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          422..521
FT                   /note="PH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          643..740
FT                   /note="PH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   ZN_FING         559..619
FT                   /note="FYVE-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   REGION          1..150
FT                   /note="Actin filament-binding"
FT   REGION          43..167
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          745..766
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        43..69
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        111..162
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         565
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         568
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         582
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         585
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         590
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         593
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         611
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   BINDING         614
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00091"
FT   MOD_RES         702
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96M96"
FT   MOD_RES         716
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91ZT5"
SQ   SEQUENCE   766 AA;  86454 MW;  E34831DC0B0B334C CRC64;
     MEESNPAPTS CASKGKHSKV SDLISHFEGG SVLSSYTDVQ KDSTMNLNIP QTPRQHGLTS
     TTPQKLPSHK SPQKQEKDSD QNQGQHGCLA NGVAAAQSQM ECETEKEAAL SPETDTQTAA
     ASPDAHVLNG VRNETTTDSA SSVTNSHDEN ACDSSCRTQG TDLGLPSKEG EPVIEAELQE
     RENGLSTEGL NPLDQHHEVK ETNEQKLHKI ATELLLTERA YVSRLNLLDQ VFYCKLLEEA
     NRGSFPAEMV NKIFSNISSI NAFHSKFLLP ELEKRMQEWE TTPRIGDILQ KLAPFLKMYG
     EYVKGFDNAV ELVKNMTERV PQFKSVTEEI QKQKICGSLT LQHHMLEPIQ RIPRYEMLLK
     DYLKKLSPDA PDWNDAKKSL EIISTAASHS NSAIRKMENL KKLLEIYEML GEEEDIVNPS
     NELIKEGQIL KLAARNTSAQ ERYLFLFNNM LLYCVPRFSL VGSKFTVRTR VGIDGMKIVE
     THNEEYPHTF QVSGKERTLE LQASSEQDKE EWIKALQESI DAFHQRHETF RNAIAKENDI
     PLEVSTAELG KRAPRWIRDN EVTMCMKCKE SFNALTRRRH HCRACGHVVC WKCSDYKAQL
     EYDGGRLNKV CKDCYQIMSG FAESEEKKRR GILEIESAEV SGNSEVCSFL QYMEKSKPWQ
     KIWCVIPKQD PLVLYMYGAP QDVRAQATIP LLGYIVDDMP KSADLPHSFK LTQSKSVHSF
     AADSEELKQK WLKIILLAVT GETPDGPSEH LDTLDNLPGP KEKSEC
//
